Chronic Obstructive Pulmonary Disease Market Insight, Epidemiology And Market Forecast

Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable, and treatable disease characterized by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases. In the United States, the term COPD includes two main conditions—emphysema and chronic bronchitis. In emphysema, the walls between many of the air sacs are damaged. As a result, the air sacs lose their shape and become floppy.

Chronic Obstructive Pulmonary Disease Epidemiology Segmentation in the 7MM 

·        Diagnosed Prevalent cases of COPD

·        Gender-specific Diagnosed Prevalent cases of COPD

·        Age-specific Diagnosed Prevalent cases of COPD

·        Diagnosed Prevalent Cases of COPD Based on Severity of Airflow

·        Diagnosed Prevalent Cases of COPD Based on Symptoms and Exacerbation History COPD

Chronic Obstructive Pulmonary Disease Epidemiological Insights Observed in the 7MM (2020)

·        The total diagnosed prevalent population of Chronic Obstructive Pulmonary Disease in the 7MM was estimated to be 34.6 million.

·        The total diagnosed prevalent population of Chronic Obstructive Pulmonary Disease in the US was found to be 17.4 million.

·        The total Gender-specific cases of Chronic Obstructive Pulmonary Disease in the 7MM where males were found to be 6.5 million and the females were estimated to be 10.8 million in the year 2020.

Chronic Obstructive Pulmonary Disease Market Insight

The market size of Chronic Obstructive Pulmonary Disease in the 7MM was found to be USD 12,333 million in 2020.  

Chronic Obstructive Pulmonary Disease Market Drivers

·        Increasing prevalence of COPD

·        Emergence in the development of emerging therapies

·        Personalized treatments

·        Entry of the ‘Act earlier’ concept in the market

·        Improvement in diagnostic techniques

·        Growing demand for fixed-dose combinations

Chronic Obstructive Pulmonary Disease Market Barriers

·        Late recognition of COPD

·        High cost of treatment

·        Challenges in existing therapies

·        Patient-related barriers

·        Drug failure

·        Availability of generics

Chronic Obstructive Pulmonary Disease Emerging Therapies

The emerging drugs in the Chronic Obstructive Pulmonary Disease market are

·        Itepekimab (SAR440340/REGN3500/Anti-IL-33 mAb)

·        Dupixent (Dupilumab)

·        Tyvaso (Inhaled treprostinil solution)

·        Ensifentrine (RPL554)

·        Fasenra (Benralizumab)

·        CHF6001 (Tanimilast)

·        Nucala (Mepolizumab)

·        MV130 (Bactek)

·        MEDI3506

·        SelK2

·        Epeleuton (DS102)

·        NOV-14 (CSJ117)

·        Zofin

·        NTHi Mcat investigational vaccine (GSK3277511A)

·        Icenticaftor (QBW251)

·        Kalydeco (Ivacaftor/VX-770)

·        PUL-042 Inhalation Solution

·        Benlysta (Belimumab)

·        Azithromycin

·        Tezepelumab

·        Acumapimod (BCT-197)

·        BIO-11006 Inhalation Solution

Chronic Obstructive Pulmonary Disease Key Players 

The key players working in the Chronic Obstructive Pulmonary Disease market are

·        Sanofi

·        Regeneron Pharmaceuticals

·        United Therapeutics

·        Verona Pharma PLC

·        AstraZeneca

·        Chiesi Farmaceutici S.p.A

·        GlaxoSmithKline

·        Inmunotek

·        Tetherex Pharmaceuticals Corporation

·        Afimmune

·        Novartis Pharmaceuticals

·        Organicell Regenerative Medicine

·        Vertex Pharmaceuticals Incorporated

·        Pulmotect Inc.

·        Genentech

·        Amgen

·        Mereo BioPharma

·        Biomarck Pharmaceuticals

Also, read- Chronic Obstructive Pulmonary Disease Infographic | Chronic Obstructive Pulmonary Disease Market Infographic

Views: 3

Reply to This

Welcome

Welcome to the PERSONAL GROWTH SYSTEMS Information network.

Here you will be able to keep up with the latest concepts in unlocking human potential,

Philosophical, and cultural discussions are also welcome.

Please try to keep this a positive forum that focuses on solutions and positive action  No spam please.

If you have any questions, comments or discussions, please post them.

The best place to find me is on facebook or twitter if I'm not here.

Feel free to comment and make friends within the community.

You may envite as many people as you want to join our network. Have fun!

 

This page is best viewed in safari or firefox.

(add your location to the map)

 

 

Who We Are

Personal Growth Systems is a free information forum that focuses specifically on self improvement in every form.

The tools available on this site will allow members to coach and support each other in virtually any aspect of self improvement.

Please use the blog and forum pages to start a discussion so you can get started.

Get a Coach

Hiring a coach or trainer is a great way to take your self improvement goals to the next level.

© 2024   Created by David W. Rhay.   Powered by

Badges  |  Report an Issue  |  Terms of Service

Tweet Tweets by @rhaydavid